October 1, 2019
Actinogen Medical pleased with positive efficacy data for Xanamem in Alzheimer’s patients
Actinogen Medical’s trial showed cognitive improvement in healthy elderly subjects dosed with 20mg Xanamem daily, with statistically significant reduction in serum cortisol following treatment with Xanamem.